News

Zacks Investment Research on MSN2h
ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock?
ADMA Biologics ADMA reported lower-than-expected results for the first quarter. Adjusted earnings per share of 14 cents missed the Zacks Consensus Estimate of 16 cents. Revenues of $114.8 million (up ...
The Manila Times23h
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
Total Revenue of $114.8 Million (Adjusted Total Revenue (1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 Adjusted EBITDA (2) of $47.9 ...